© 2003 by European Society of Cardiology
Copyright © 2003, European Society of Cardiology
The MKK6–p38 MAPK pathway prolongs the cardiac contractile calcium transient, downregulates SERCA2, and activates NF-AT
aGenetics Cell Biology/Development, University of Minnesota, 1445 Gortner Ave, St. Paul, MN 55108, USA
bDepartment of Biology, the SDSU Heart Institute, and the Molecular Biology Institute, San Diego State University, San Diego, CA 92182, USA
cDepartment of Medicine, University of California, San Diego, Mail code 0618, 9500 Gilman Drive, La Jolla, CA 92093-0618, USA
pmcdonough{at}ucsd.edu
* Corresponding author. Tel.: +1-858-534-9938.
Objective: Our goal was to determine if the MKK6–p38 MAPK pathway regulates cardiac intracellular calcium ([Ca2+]i). We also tested if MKK6 might influence expression of SERCA2, a calcium regulatory molecule involved in relaxation, and the activity of nuclear factor of activated T-cells (NF-AT), a calcium-regulated transcription factor that participates in pathological responses to pressure-overload. Methods: Neonatal rat ventricular myocytes were transfected with MKK6(Glu), an activator of p38 MAPK. Green fluorescent protein (GFP) was used as transfection marker and [Ca2+]i was evaluated via indo-1. SERCA2 expression was assayed via Northern and Western techniques. The activity of the rat SERCA2 gene promoter and NF-AT-dependent gene expression were monitored with reporter genes. Myocyte contractility was regulated by electrical pacing. Results: MKK6(Glu) prolonged decay of the contractile calcium transients, downregulated SERCA2 expression, and reduced the activity of the rat SERCA2 gene promoter. Diastolic [Ca2+]i in myocytes pacing at 1–2 Hz was dramatically increased by MKK6(Glu). NF-AT-dependent gene expression was activated by MKK6(Glu) and by pacing of contractions in a synergistic manner. Overexpression of SERCA2 mitigated the effects of MKK6(Glu) on [Ca2+]i and NF-AT. Conclusions: The MKK6(Glu)–p38 MAPK pathway prolongs the decay phase of the cardiac contractile calcium by downregulating SERCA2, increasing diastolic [Ca2+]i which activates NF-AT. The ability of SERCA2 over-expression to reduce NF-AT activity represents a potential novel therapeutic effect of SERCA2 that should be further considered in the development of cardiac gene therapy strategies.
KEYWORDS Calcium (cellular); Signal transduction; Ca-pump; Gene expression; Gene therapy
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Xu, C. S. Kappler, S. K. Mani, N. R. Shepherd, L. Renaud, P. Snider, S. J. Conway, and D. R. Menick Chronic Administration of KB-R7943 Induces Up-regulation of Cardiac NCX1 J. Biol. Chem., October 2, 2009; 284(40): 27265 - 27272. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Toischer, H. Kogler, G. Tenderich, C. Grebe, T. Seidler, P. N. Van, K. Jung, R. Knoll, R. Korfer, and G. Hasenfuss Elevated Afterload, Neuroendocrine Stimulation, and Human Heart Failure Increase BNP Levels and Inhibit Preload-Dependent SERCA Upregulation Circ Heart Fail, November 1, 2008; 1(4): 265 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger Designing Heart Performance by Gene Transfer Physiol Rev, October 1, 2008; 88(4): 1567 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-K. Kim, J. Suarez, Y. Hu, P. M. McDonough, C. Boer, D. J. Dix, and W. H. Dillmann Deletion of the Inducible 70-kDa Heat Shock Protein Genes in Mice Impairs Cardiac Contractile Function and Calcium Handling Associated With Hypertrophy Circulation, June 6, 2006; 113(22): 2589 - 2597. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Heidkamp, B. T. Scully, K. Vijayan, S. J. Engman, E. L. Szotek, and A. M. Samarel PYK2 regulates SERCA2 gene expression in neonatal rat ventricular myocytes Am J Physiol Cell Physiol, August 1, 2005; 289(2): C471 - C482. [Abstract] [Full Text] [PDF] |
||||




